Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Biton

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
CNS Drugs|August 19, 2003
Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsyVictor Biton
The Neurologist|May 12, 2006
Weight change and antiepileptic drugs: health issues and criteria for appropriate selection of an antiepileptic agentVictor Biton
Expert Review of Neurotherapeutics|November 7, 2008
Lacosamide for the treatment of diabetic neuropathic painVictor Biton
Clinical Neuropharmacology|September 1, 2007
Clinical pharmacology and mechanism of action of zonisamideVictor Biton
Expert Review of Neurotherapeutics|June 2, 2012
Lacosamide for the treatment of partial-onset seizuresVictor Biton
Expert Opinion on Drug Metabolism & Toxicology|November 28, 2006
Pharmacokinetics, toxicology and safety of lamotrigine in epilepsyVictor Biton
Expert Review of Neurotherapeutics|April 28, 2005
Zonisamide: newer antiepileptic agent with multiple mechanisms of actionVictor Biton
Archives of Neurology|November 16, 2005
Topiramate in patients with juvenile myoclonic epilepsyVictor Biton, Blaise F D Bourgeois,
Diabetes Research and Clinical Practice|April 14, 2012
A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trialDavid Sandercock, Marilou Cramer, Victor Biton, et al.
European Journal of Pain (London, England)|July 16, 2008
Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trialAziz Shaibani, Victor Biton, Richard Rauck, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
CNS Drugs|August 19, 2003
Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsyVictor Biton
The Neurologist|May 12, 2006
Weight change and antiepileptic drugs: health issues and criteria for appropriate selection of an antiepileptic agentVictor Biton
Expert Review of Neurotherapeutics|November 7, 2008
Lacosamide for the treatment of diabetic neuropathic painVictor Biton
Clinical Neuropharmacology|September 1, 2007
Clinical pharmacology and mechanism of action of zonisamideVictor Biton
Expert Review of Neurotherapeutics|June 2, 2012
Lacosamide for the treatment of partial-onset seizuresVictor Biton
Expert Opinion on Drug Metabolism & Toxicology|November 28, 2006
Pharmacokinetics, toxicology and safety of lamotrigine in epilepsyVictor Biton
Expert Review of Neurotherapeutics|April 28, 2005
Zonisamide: newer antiepileptic agent with multiple mechanisms of actionVictor Biton
Archives of Neurology|November 16, 2005
Topiramate in patients with juvenile myoclonic epilepsyVictor Biton, Blaise F D Bourgeois,
Diabetes Research and Clinical Practice|April 14, 2012
A gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trialDavid Sandercock, Marilou Cramer, Victor Biton, et al.
European Journal of Pain (London, England)|July 16, 2008
Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trialAziz Shaibani, Victor Biton, Richard Rauck, et al.
Pageof 5